News
54m
Money Talks News on MSNAre Your Weight-Loss Drugs Real? Novo Nordisk Sounds Alarm on KnockoffsOne in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a ...
WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...
Ozempic a drug touted as a magical driving force for weight loss may be negatively affecting intimacy between couples ...
Patients with overweight or obesity and heart failure with preserved ejection fraction that have unintentional weight loss have worse outcomes.
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.
3h
Barchart on MSNWeightWatchers Has Exited Bankruptcy. How Should You Play WW Stock Here?Many health and wellness stocks have faced challenges in recent years as GLP-1 weight-loss drugs like Ozempic and Wegovy ...
Some users of weight loss jabs have reported losing more than just the pounds-they've taken to online forums in their hundreds to complain that their entire sex drive has dropped off.
SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB ...
AstraZeneca spinout Dizal Pharmaceuticals won an FDA accelerated approval for sunvozertinib for previously treated EGFR ex 20-mutated non-small cell lung cancer. To be marketed as Zegfrovy, the oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results